Hospitals & Nursing Homes held the leading position in the nasogastric tube market in 2025, accounting for a 62.69% share. This dominance is sustained by the concentration of acute care, post-surgical recovery, and long-term feeding support within institutional settings where nasogastric tube placement, monitoring, and replacement are routinely managed by trained clinical staff. The segment’s leadership also reflects the steady use of nasogastric tubes in patients requiring supervised nutrition delivery, medication administration, and short-term gastrointestinal decompression, all of which are more consistently handled in hospital and nursing home environments.

Home Care is emerging as the fastest-growing segment in the nasogastric tube market as care delivery increasingly shifts beyond conventional facilities toward lower-cost and more patient-centered settings. Growth in this segment is being reinforced through the rising practical feasibility of managing enteral feeding at home for selected patients who require ongoing nutritional support but not continuous institutional supervision. Compared with hospitals and nursing homes, home care is gaining momentum because it aligns with the broader move toward extended recovery and chronic care management outside inpatient settings, creating stronger demand for nasogastric tube use in residential care contexts.

Patient Type Segment Analysis: Adult (Largest Segment) vs Geriatric (Fastest-Growing Segment)

Adult remained the largest patient type in the nasogastric tube market in 2025, with a 39.11% share. Its leading position reflects the broad clinical use of nasogastric tubes across adult care settings, where patients frequently require temporary enteral nutrition, gastric decompression, or medication delivery during surgery recovery, critical care, and treatment of gastrointestinal or neurological conditions. The segment maintains its share because adults represent the widest treatment population across hospital, nursing, and transitional care environments where nasogastric tube intervention is commonly integrated into routine care pathways.

Geriatric is the fastest-growing patient type in the nasogastric tube market, encouraged by the increasing care needs of older patients who are more likely to experience swallowing difficulties, frailty, and conditions that limit normal oral intake. This segment is gaining momentum relative to other patient groups because elderly patients often require sustained nutritional support and closer feeding management across both institutional and home-based care settings. As a result, the practical demand for nasogastric tube use is rising faster in geriatric care, where age-related complications create more frequent and prolonged dependence on assisted feeding methods.